scotts miracle-gro co. - SMG

SMG

Close Chg Chg %
65.14 -0.10 -0.15%

Closed Market

65.04

-0.10 (0.15%)

Volume: 838.63K

Last Updated:

Nov 11, 2026, 3:59 PM EDT

Company Overview: scotts miracle-gro co. - SMG

SMG Key Data

Open

$64.80

Day Range

63.57 - 65.16

52 Week Range

47.90 - 75.34

Market Cap

$3.86B

Shares Outstanding

58.22M

Public Float

44.53M

Beta

1.85

Rev. Per Employee

N/A

P/E Ratio

37.74

EPS

$1.77

Yield

405.34%

Dividend

$0.66

EX-DIVIDEND DATE

Nov 20, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.18M

 

SMG Performance

1 Week
 
0.65%
 
1 Month
 
30.63%
 
3 Months
 
6.88%
 
1 Year
 
14.81%
 
5 Years
 
-63.18%
 

SMG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About scotts miracle-gro co. - SMG

Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. The firm’s products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

SMG At a Glance

Scotts Miracle-Gro Co.
14111 Scottslawn Road
Marysville, Ohio 43041
Phone 1-937-644-0011 Revenue 3.29B
Industry Chemicals: Agricultural Net Income 103.90M
Sector Process Industries Employees N/A
Fiscal Year-end 09 / 2027
View SEC Filings

SMG Valuation

P/E Current 36.809
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 28.504
Price to Sales Ratio 0.90
Price to Book Ratio N/A
Price to Cash Flow Ratio 7.94
Enterprise Value to EBITDA 9.296
Enterprise Value to Sales 1.515
Total Debt to Enterprise Value 0.407

SMG Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 24.29
Total Asset Turnover 1.199

SMG Liquidity

Current Ratio 1.217
Quick Ratio 0.402
Cash Ratio 0.01

SMG Profitability

Gross Margin 32.397
Operating Margin 14.315
Pretax Margin 8.453
Net Margin 3.159
Return on Assets 7.108
Return on Equity N/A
Return on Total Capital 11.776
Return on Invested Capital 11.094

SMG Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 122.50
Total Debt to Total Assets 73.937
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 120.355
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Scotts Miracle-gro Co. - SMG

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
3.55B 3.55B 3.41B 3.29B
Sales Growth
-9.50% +0.04% -3.93% -3.64%
Cost of Goods Sold (COGS) incl D&A
2.74B 2.63B 2.36B 2.22B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
173.50M 151.00M 144.60M 65.10M
Depreciation
148.30M 135.30M 132.30M 62.40M
Amortization of Intangibles
25.20M 15.70M 12.30M 2.70M
COGS Growth
-6.92% -4.08% -10.08% -5.85%
Gross Income
813.30M 926.50M 1.05B 1.07B
Gross Income Growth
-17.23% +13.92% +13.49% +1.33%
Gross Profit Margin
+22.90% +26.08% +30.81% +32.40%
2023 2024 2025 2026 5-year trend
SG&A Expense
528.70M 545.10M 591.70M 594.70M
Research & Development
- 35.70M 34.60M 34.80M
Other SG&A
493.00M 510.50M 556.90M 594.70M
SGA Growth
-9.16% +3.10% +8.55% +0.51%
Other Operating Expense
- - - -
-
Unusual Expense
479.70M 157.90M 66.50M 51.70M
EBIT after Unusual Expense
(195.10M) 223.50M 393.30M 419.10M
Non Operating Income/Expense
(68.60M) (76.60M) (36.90M) (28.50M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
(101.10M) (68.10M) (2.80M) 3.00M
Interest Expense
189.60M 170.50M 134.70M 112.60M
Interest Expense Growth
+63.45% -10.07% -21.00% -16.41%
Gross Interest Expense
191.70M 171.60M 135.80M 112.60M
Interest Capitalized
- 2.10M 1.10M 1.10M
Pretax Income
(453.30M) (23.60M) 221.70M 278.00M
Pretax Income Growth
+18.78% +94.79% +1,039.41% +25.39%
Pretax Margin
-12.76% -0.66% +6.50% +8.45%
Income Tax
(73.20M) 11.30M 76.50M 83.10M
Income Tax - Current - Domestic
- 4.30M 4.90M (2.90M)
Income Tax - Current - Foreign
- 1.60M (5.30M) 2.60M
Income Tax - Deferred - Domestic
- (67.30M) 7.80M 70.40M
Income Tax - Deferred - Foreign
- (11.80M) 3.90M 6.40M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
(101.10M) (68.10M) (2.80M) 3.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(380.10M) (34.90M) 145.20M 194.90M
Minority Interest Expense
- - - -
-
Net Income
(380.10M) (34.90M) 145.20M 194.90M
Net Income Growth
+13.12% +90.82% +516.05% +34.23%
Net Margin Growth
-10.70% -0.98% +4.25% +5.93%
Extraordinaries & Discontinued Operations
- - - (91.00M)
-
Discontinued Operations
- - - (91.00M)
-
Net Income After Extraordinaries
(380.10M) (34.90M) 145.20M 103.90M
Preferred Dividends
- - - -
-
Net Income Available to Common
(380.10M) (34.90M) 145.20M 103.90M
EPS (Basic)
-6.7875 -0.6144 2.5208 1.7883
EPS (Basic) Growth
+13.90% +90.95% +510.29% -29.06%
Basic Shares Outstanding
56.00M 56.80M 57.60M 58.10M
EPS (Diluted)
-6.7875 -0.6144 2.4736 1.758
EPS (Diluted) Growth
+13.90% +90.95% +502.60% -28.93%
Diluted Shares Outstanding
56.00M 56.80M 58.70M 59.10M
EBITDA
458.10M 532.40M 604.40M 535.90M
EBITDA Growth
-9.43% +16.22% +13.52% -11.33%
EBITDA Margin
+12.90% +14.99% +17.71% +16.29%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 73.60
Number of Ratings 9 Current Quarters Estimate -0.954
FY Report Date 12 / 2026 Current Year's Estimate 4.79
Last Quarter’s Earnings -2.16 Median PE on CY Estimate N/A
Year Ago Earnings 4.48 Next Fiscal Year Estimate 5.197
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 8 8
Mean Estimate -0.95 4.49 4.79 5.20
High Estimates -0.84 4.61 4.87 5.43
Low Estimate -1.18 4.39 4.75 5.09
Coefficient of Variance -12.93 2.05 0.99 2.39

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 4
OVERWEIGHT 1 1 1
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Scotts Miracle-gro Co. - SMG

Date Name Shares Transaction Value
Oct 30, 2026 Nathan E. Baxter President and CEO; Director 102,315 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 30, 2026 Dimiter Todorov EVP, CLO & CORPORATE SECRETARY 28,961 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 30, 2026 Mark J. Scheiwer EVP, CFO & CAO 16,497 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 6, 2026 Stephen L. Johnson Director 30,323 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 6, 2026 Mark J. Scheiwer EVP, CFO & CAO 13,834 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $49.02 per share 678,142.68
Oct 6, 2026 Brian E. Sandoval Director 20,190 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 1, 2026 James Hagedorn CEO; Director 245,450 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 10, 2026 Mark J. Scheiwer EVP, CFO & CAO 1,394 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 10, 2026 Mark J. Scheiwer EVP, CFO & CAO 453 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 30, 2026 Nathan Baxter President and COO 60,917 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $65.38 per share 3,982,753.46
Apr 2, 2026 James Hagedorn Chairman & CEO; Director 238,673 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 2, 2026 James Hagedorn Chairman & CEO; Director 88,555 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $60.2 per share 5,331,011.00
Mar 10, 2026 Mark D. Kingdon Director 552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 Adam Hanft Director 552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 David C. Evans Director 552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 James Hagedorn Chairman & CEO; Director 237,393 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 Katherine Hagedorn Littlefield Director 33 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 Peter E. Shumlin Director 845 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 Edith Aviles Director 552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 10, 2026 Nick Miaritis Director 194 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Scotts Miracle-Gro Co. in the News